Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-13T02:41:30.739Z Has data issue: false hasContentIssue false
  • English
  • Français

The use of Selective Serotonin Re-uptake Inhibitors (SSRIs) in the treatment of depressive disorders in children and adolescents

Published online by Cambridge University Press:  11 October 2011

Anthony James
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials
Information
Epidemiology and Psychiatric Sciences , Volume 14 , Issue 2 , June 2005 , pp. 63 - 67
Copyright
Copyright © Cambridge University Press 2005

References

REFERENCES

American College of Neuropsychopharmacology (2004). Executive Summary. Preliminary Report of Task Force on SSRIs and Suicidal Behaviour in Youth. Retrieved January 11, 2005 from http://www.acnp.org/exec_summary.pdfGoogle Scholar
BBC News (2003). Panorama: Seroxat: E-mails from the edge. Retrieved January 11, 2005 from http://news.bbc.co.uk/l/hi/programmes/panorama/2982797.stmGoogle Scholar
Brent, D.A. & Birmaher, B. (2004). British warnings on SSRIs questioned. Journal American Academy of Child and Adolescent Psychiatry 43, 379–380.Google Scholar
Carlsten, A., Waern, M., Ekedahl, A. & Ranstam, J. (2001). Antidepressant medication and suicide in Sweden. Phannacoepidemiology and Drug Safety 10, 525–530.Google Scholar
Committee on Safety of Medicines (2003). Selective Serotonin Reuptake inhibitors (SSRIs) - overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents: summary of clinical trials. London: Committee on Safety of Medicines. Retrieved January 12, 2005 from http://medicines.mhra.gov.uk/ourwork/monitorsafequalmed/safetymessages/SSRIfinal.pdfGoogle Scholar
Compton, S.N., March, J.S., Brent, D., Albano, A.M., Weersing, V.R. & Curry, J. (2004). Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. Journal of the American Academy of Child and Adolescent Psychiatry 43, 930–959.CrossRefGoogle Scholar
Emslie, G.J., Rush, A.J., Weinberg, W.A., Kowatch, R.A., Hughes, C.W., Carmody, T. & Rintelmann, J. (1997). A double-blind, randomised, placebo-controlled trial of Fluoxetine in children and adolescents with depression. Archives of General Psychiatry 54, 1031–1037.Google Scholar
Emslie, G.J., Heiligenstein, J.H., Wagner, K.D., Hoog, S.L., Ernest, D.E., Brown, E., Nilsson, M. & Jacobson, J.G. (2002). Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. American Academy of Child and Adolescent Psychiatry 41,1205–1215.Google Scholar
Fergusson, D.M. & Woodward, L.J. (2002). Mental health, educational, and social role outcomes of adolescents with depression. Archives of General Psychiatry 59, 225–231.Google Scholar
Garland, E.J. (2004). Facing the evidence: antidepressant treatment in children and adolescents. Canadian Medical Association 170, 489–1345.Google Scholar
Gray, D., Moskos, M. & Keller, T. (2003). Utah Youth Suicide Study New Findings. Presented at the Annual Meeting of the American Association of Suicidology, Sante Fe, New Mexico.Google Scholar
Gunnell, D. & Ashby, D. (2004). Antidepressants and suicide: what is the balance of benefit and harm. British Medical Journal 329(7456), 34–38.CrossRefGoogle Scholar
Harrington, R., Whittaker, J., Shoebridge, P. & Campbell, F. (1998). Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder. British Medical Journal 316,1559–1563.CrossRefGoogle Scholar
Hawton, K., Rodham, K., Evans, E. & Weatherall, R. (2002). Deliberate self harm in adolescents: self report survey in schools in England. British Medical Journal 325,1207–1211.Google Scholar
Hawton, K., Hall, S., Simkin, S., Bale, L., Bond, A., Codd, S. & Stewart, A. (2003). Deliberate self-harm in adolescents: a study of characteristics and trends in Oxford, 1900-2000. Journal of Child Psychology and Psychiatry 44, 1191–1198.Google Scholar
Hazell, P., O'Connell, D., Heathcote, D., Robertson, J. & Henry, D. (1995). Efficacy of tricyclics drugs in treating child and adolescent depression: a meta-analysis. British Medical Journal 310, 897–901.Google Scholar
Hazell, P., O'Connell, D., Heathcote, D. & Henry, D. (2002). Tricyclic drugs for depression in children and adolescents. Cochrane Database of Systematic Reviews, Issue 2.Google Scholar
Healy, D. 2003). Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychotherapy and Psychosomatics 72, 71–79.Google Scholar
Isacsson, G. (2000). Suicide prevention-a medical breakthrough? Acta Psychiatrica Scandanavica 102, 113–117.Google Scholar
Isacsson, G., Holmgren, P., Druid, H. & Bergman, U. (1997). The utilisation of antidepressants - a key issue in the prevention of suicide: an anlysis of 5281 suicides in Sweden during the period 1992-1994. Acta Psychiatrica Scandanavica 96, 94–100.Google Scholar
Jick, H., Kaye, J.A. & Jick, S.S. (2004). Antidepressants and the risk of suicidal behaviours. Journal of the American Medical Association 292, 338–343.Google Scholar
Jureidini, J.N., Doecke, C.J., Mansfield, P.R., Haby, M.M., Menkes, D.B. & Tonkin, A.L. (2004). Efficacy and safety of antidepressants for children and adolescents. British Medical Journal 328, 879–883.Google Scholar
Keller, M.B., Ryan, N.D., Strober, M., Klein, R.G., Kutcher, S.P., Birmaher, B., Hagino, O.R., Koplewicz, H., Carlson, G.A., Clarke, G.N., Emslie, G.J., Feinberg, D., Geller, B., Kusumakar, V., Papatheodorou, G., Sack, W.H., Sweeney, M., Wagner, K.D., Weller, E.B., Winters, N.C., Oakes, R. & McCafferty, J.P. (2001). Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry 40, 762–772.Google Scholar
Khan, A., Khan, S., Kolts, R. & Brown, W.A. (2003). Suicide rates in clinical trial of SSRIs, other antidepressants, and placebo: analysis of FDA reports. American Journal of Psychiatry 160, 90–792.CrossRefGoogle Scholar
Mandoki, M.W., Tapia, M.R., Tapia, M.A., Sumner, G.S. & Parker, J.L. (1997). Venlafaxine in the treatment of children and adolescents with major depression. Psychophannacology Bulletin 33, 149–154.Google Scholar
McClure, M. (2001). Suicide in children and adolescents in England and Wales 1970-1998. British Medical Journal 178, 469–474.Google Scholar
Mufson, L., Dorta, P., Wickramaratne, P., Nomura, Y., Olfson, M. & Weissman, M.M. (2004). A randomized effectiveness trial of inter-personal psychotherapy for depressed adolescents. Archives of General Psychiatry 61, 577–584.Google Scholar
Nutt, D.J. (2003). Death and dependence: current controversies over the selective serotonin Psxchopharmacology 17, 355–364.Google Scholar
Ohberg, A., Vuori, E., Klaukka, T. & Lonnqvist, J. (1998). Antidepressants and suicide mortality Journal of Affective Disorders 50, 225–233.Google Scholar
Olfson, M., Shaffer, D., Marcus, S.C. & Greenberg, T. (2003). Relationship between antidepressant medication treatment and suicide in adolescents. Archives of General Psychiatry 60, 978–982.Google Scholar
Pich, J., Came, X., Arnaiz, J.A., Gomez, B., Trilla, A. & Rodes, J. (2003). Role of a research ethics committee in follow-up and publication of results. Lancet 361, 1015–1016.Google Scholar
Poznanski, E.O. & Mokros, H.B. (1996). Manual: Children's Depression Rating Scale-Revised. Western Psychological Services: Los Angeles.Google Scholar
Poznanski, E.O., Cook, S.C. & Carroll, B.J. (1979). A depression rating scale for children. Pediatrics 64, 442–450.Google Scholar
Ramchandani, P. (2004'). Treatment of major depressive disorder in children and adolescents: most selective serotonin reuptake inhibitors are no longer recommended. British Medical Journal 328, 518–520.Google Scholar
Ramchandani, P. (2004b). A question of balance: how safe are the medicines that are prescribed to children? Nature 430, 401–402.Google Scholar
Rao, U., Weissman, M.M., Martin, J.A. & Hammond, R.W. (1993). Childhood depression and risk of suicide: preliminary report of a longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry 32, 21–27.Google Scholar
Simeon, J.G., Dinicola, V.F., Fergusson, H.B. & Copping, W. (1990). Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Progress in Neuro-Psychopharmacology & Biological Psychiatry 14, 791–795.Google Scholar
Treatment for Adolescents With Depression Study Team (2004). Fluoxetine, cognitive-behavioral therapy, and their contribution for adolescent with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. Journal of American Medical Association 292, 807–820.Google Scholar
US Food and Drugs Administration (2004). FDA Statement on Recommendations of the Psychopharmacologic Drugs and Pediatric Advisory Committee. Retrieved January 11, 2005 from http://www.fda.gov/bbs/topics/news/2004/NEW01116.htmlGoogle Scholar
Wagner, K. D., Ambrosini, P., Rynn, M., Wohlberg, C, Yang, R., Greenbaum, M.S., Childress, A., Donnelly, C. & Deas, D. (2003). Sertraline Pediatric Depression Study GroupEfficacy of sertraline in the treatment of children and adolescents with major depressive dis-order. Journal of the American Medical Association 290, 1033–1041.Google Scholar
Wagner, K.D., Robb, A.S., Findling, R.L., Jin, J., Gutierrez, M.M. & Heydorn, W.E. (2004). A randomised, placebo-controlled Trial of citalopram for the treatment of major depression in children and adolescents. American Journal Psychiatry 161, 1079–1083.Google Scholar
Wessely, S. & Kerwin, R. (2004). Suicide risk and the SSRIs. Journal of the American Medical Association 292, 379–381.Google Scholar
World Health Organisation (2003). Suicide Prevention and special programmes. Country reports and charts available. Retrieved January 11, 2005 from http://www.who.int/mentaUiealth/prevention/suicide/country_reports/en/Google Scholar
Whittington, C.J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A. & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363, 341–1345.Google Scholar